Volume 4, May 2018


The Importance of Diversity in Clinical Research
Despite what is known about how certain groups of people may respond differently to disease; traditionally, the majority of cardiovascular clinical research study participants are white men. Increasing diversity in clinical research studies is a priority for the Food and Drug Administration and the ADAPTABLE team in making sure results provide evidence that is relevant and helpful to a wide range of people. Diversity in clinical research studies helps ensure that the results will have an impact on the people the study is intended to help.

VIEW NEWSLETTER FOR MAY 2018 (pdf)

 

SaveSave

SaveSave

tertiary sidebar container